Tony Butler
Stock Analyst at Rodman & Renshaw
(0.93)
# 3,768
Out of 4,893 analysts
105
Total ratings
31.37%
Success rate
-14.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $9.54 | +162.19% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $2.52 | +336.51% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.93 | +832.64% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $2.48 | +504.84% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.36 | +2,152.25% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.62 | +2,488.16% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.27 | +3,545.64% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.16 | +762.07% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $59.00 | +27.12% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $55.11 | -36.49% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $2.29 | +2,520.09% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.69 | +669.23% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $8.09 | +518.05% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.26 | +1,090.48% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.39 | +6,366.63% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.19 | +1,160.50% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.82 | +161.78% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $1.62 | +949.38% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $5.92 | +2,704.05% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $10.77 | +457.10% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $2.29 | +10,380.35% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.68 | +782.35% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $4.48 | +7,935.71% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $3.49 | -42.69% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.90 | +284.62% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.80 | +455.56% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.85 | +426.32% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $12.16 | +804.61% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.47 | +16,986.72% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $9.54
Upside: +162.19%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $2.52
Upside: +336.51%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.93
Upside: +832.64%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.48
Upside: +504.84%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.36
Upside: +2,152.25%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.62
Upside: +2,488.16%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.27
Upside: +3,545.64%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.16
Upside: +762.07%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $59.00
Upside: +27.12%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $55.11
Upside: -36.49%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $2.29
Upside: +2,520.09%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.69
Upside: +669.23%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $8.09
Upside: +518.05%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.26
Upside: +1,090.48%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.39
Upside: +6,366.63%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.19
Upside: +1,160.50%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $3.82
Upside: +161.78%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $1.62
Upside: +949.38%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $5.92
Upside: +2,704.05%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $10.77
Upside: +457.10%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $2.29
Upside: +10,380.35%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.68
Upside: +782.35%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $4.48
Upside: +7,935.71%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $3.49
Upside: -42.69%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $3.90
Upside: +284.62%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.80
Upside: +455.56%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $2.85
Upside: +426.32%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $12.16
Upside: +804.61%
Mar 2, 2020
Initiates: Buy
Price Target: $80
Current: $0.47
Upside: +16,986.72%